SCHEMBL9944097

SCHEMBL9944097

Cc1cc(C(=O)Nc2ccc(C(=O)O)c(F)c2)cc(Cl)c1OC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 3/20 0.47
RARA P10276 1/20 0.47
RARB P10826 1/20 0.47
RARG P13631 1/20 0.47
CPT2 P23786 3/20 0.46
CPT1A P50416 3/20 0.46
CPT1B Q92523 3/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MAPT P10636 1/20 0.46
ALDH1A1 P00352 2/20 0.45
ALOX12 P18054 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944205 0.92 PLAU (0.47) PLAUNPC1RAB9AMAPTTAS1R3
SCHEMBL9944084 0.90 RAB9A (0.51) PLAUNPC1RAB9AMAPTALDH1A1
SCHEMBL1458495 0.89 PLAU (0.47) PLAURARARARBRARGCPT2
SCHEMBL9944146 0.89 TAS1R3 (0.54) RARARARBRARGCPT2CPT1A
SCHEMBL1458621 0.87 PLAU (0.47) PLAURARARARBRARGNPC1
SCHEMBL1457717 0.86 MAPT (0.47) PLAURARARARBRARGCPT2
SCHEMBL9944148 0.86 RAB9A (0.58) PLAURARARARBRARGCPT2
SCHEMBL9944105 0.86 RARA (0.47) PLAURARARARBRARGCPT2
SCHEMBL9944076 0.85 RAB9A (0.50) PLAUNPC1RAB9AMAPTALDH1A1
SCHEMBL1458271 0.85 TAS1R3 (0.50) PLAURARARARBRARGCPT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447028-B2 Therapeutic aryl-amido-aryl compounds and their use KING'S COLLEGE LONDON (GB) 2016-09-20 US disclosed
US-20160039747-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use KING'S COLLEGE LONDON (GB) 2016-02-11 US disclosed
US-20120149737-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use KING'S COLLEGE LONDON (GB) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149737-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use RARA, RARB, RARG PLAU 4014/4885RARA 1/4885RARB 2/4885
US-20160039747-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use RARA, RARB, RARG PLAU 4014/4885RARA 1/4885RARB 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.